SEC Form 4 · accession 0000719135-19-000010
Apyx Medical Corp · APYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Moshe Citronowicz
Officer — Sr. V.P. of Operations
Period of report
Jan 9, 2019
Accepted (ET)
Feb 11, 2019 · 7:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000719135
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Option to Buy)F1 | $7.91 | Jan 9, 2019 | A | 72,000 | A | Jan 9, 2022 | Jan 9, 2029 | Common Stock | 72,000 | 72,000 | D |
Explanation of responses
- F1Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.